Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 407
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02992704 | Peg-interferon for Inactive Chronic Hepatitis B Carriers | ||
| NCT05765084 | Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma | ||
| NCT05075538 | COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 | ||
| NCT04470947 | Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies | ||
| NCT00477048 | Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity | ||
| NCT00433589 | Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes | ||
| NCT00193609 | Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site | ||
| NCT03324633 | Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With HIV and HCV | ||
| NCT00895206 | Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study | ||
| NCT00752336 | Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation | ||
| NCT00963534 | Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma. | ||
| NCT04888221 | Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement | ||
| NCT02319941 | Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes | ||
| NCT00620269 | Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III | ||
| NCT00744640 | Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma | ||
| NCT01596790 | COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer | ||
| NCT02060669 | Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer | ||
| NCT01524679 | Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen | ||
| NCT04332822 | A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma | ||
| NCT05396937 | Efficacy and Safety of T+A+RAD in HCC | ||
| NCT01996267 | Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 | ||
| NCT00407732 | Overcoming Psychiatric Barriers to the Treatment of Hepatitis C | ||
| NCT01472029 | Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach | ||
| NCT00910676 | Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors | ||
| NCT00536640 | Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab | ||
| NCT04462276 | Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease | ||
| NCT03192215 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | ||
| NCT03590535 | 5th Generation cTnT in ED ACS | ||
| NCT02739594 | Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma | ||
| NCT00724022 | Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation | ||
| NCT02284633 | Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer | ||
| NCT02925234 | The Drug Rediscovery Protocol (DRUP Trial) | ||
| NCT04947605 | Epidemiological Landscape of Cervical Cancer in Latin America | ||
| NCT05017142 | Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) | ||
| NCT03385668 | Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies | ||
| NCT04896710 | COVID-19 Rapid Testing for Self-Administration Among an Asymptomatic Sample | ||
| NCT00626197 | A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) | ||
| NCT05911178 | Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease | ||
| NCT04661358 | Fenofibrate for Prevention of DR Worsening | ||
| NCT05966233 | R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma | ||
| NCT04161248 | Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma | ||
| NCT00485589 | A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM) | ||
| NCT01935492 | 8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer | ||
| NCT01326559 | Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) | ||
| NCT01368848 | Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) | ||
| NCT02708680 | Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In | ||
| NCT05754502 | Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy | ||
| NCT03679455 | A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1 | ||
| NCT01770301 | Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR) | ||
| NCT00938444 | Evaluation of the BRADA and ABILHAND Questionnaires |
